Virginia Cancer Specialist

Fairfax, Virginia 22031

We've found

3 trials

at this facility

Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Fairfax, VA

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Fairfax, VA

MGC018 With or Without MGA012 in Advanced Solid Tumors

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Fairfax, VA

Use our guide to learn which trials are right for you!